Amylyx Pharmaceuticals In... (AMLX)
NASDAQ: AMLX
· Real-Time Price · USD
9.90
-0.05 (-0.50%)
At close: Sep 05, 2025, 10:15 AM
Amylyx Pharmaceuticals Revenue
Amylyx Pharmaceuticals reported an annual revenue of $87.37M, reflecting a -77.06% growth. For the quarter ending June 30, 2025, Amylyx Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
87.37M
Revenue Growth
-77.06%
Price / Sales Ratio
2.95
Revenue / Employee
710.33K
Employees
123
Market Cap
882.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 87.37M | -77.06% |
| Dec 31, 2023 | 380.79M | +1612.94% |
| Dec 31, 2022 | 22.23M | +7700.00% |
| Dec 31, 2021 | 285K | -56.15% |
| Dec 31, 2020 | 650K | -54.42% |
| Dec 31, 2019 | 1.43M | n/a |